astragaloside a has been researched along with Cancer of Cervix in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, G; Li, X; Li, Y; Shen, L; Song, X; Wang, X; Xu, X | 1 |
| Cai, Y; He, Z; Xia, C | 1 |
| Huang, H; Nie, C; Qin, X; Zhang, L; Zhou, J | 1 |
3 other study(ies) available for astragaloside a and Cancer of Cervix
| Article | Year |
|---|---|
Astragaloside IV suppresses the migration and EMT progression of cervical cancer cells by inhibiting macrophage M2 polarization through TGFβ/Smad2/3 signaling.
Topics: Cell Line, Tumor; Epithelial-Mesenchymal Transition; Female; Humans; Interleukin-10; Macrophages; Smad2 Protein; Transforming Growth Factor beta; Uterine Cervical Neoplasms | 2023 |
Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
Topics: Animals; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drugs, Chinese Herbal; Endoribonucleases; Female; Gene Ontology; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Protein Interaction Maps; Proteome; Proteomics; Saponins; Signal Transduction; Thymosin; Trans-Activators; Triterpenes; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Topics: Animals; Astragalus propinquus; Cell Line, Tumor; Cell Movement; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Female; Humans; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Saponins; Transforming Growth Factor beta1; Triterpenes; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays | 2019 |